Literature DB >> 28405802

Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4.

Yuta Okamura1, Kosuke Otani1, Akihiro Sekiguchi1, Taisuke Kogane1, Chiharu Kakuda1, Yuzaburo Sakamoto1, Tomoko Kodama1, Muneyoshi Okada1, Hideyuki Yamawaki2.   

Abstract

Fatty acid-binding protein (FABP) 4 is an adipocytokine mainly expressed in adipocyte and macrophage. Blood FABP4 is related not only to metabolic disorders including insulin resistance and atherosclerosis but also increased blood pressure. We tested the hypothesis that FABP4 plays roles in pathogenesis of hypertension development including proliferation, migration, and inflammation of vascular smooth muscle cells (SMCs) as well as contractile reactivity. FABP4 alone had no influence on proliferation, migration, and inflammation of rat mesenteric arterial SMCs, while it significantly enhanced smooth muscle contraction and increases of systolic blood pressure (SBP) induced by noradrenaline (NA). BMS-309403, an FABP4 inhibitor, significantly inhibited platelet-derived growth factor-BB-induced DNA synthesis and migration via preventing p38 and HSP27 activation. Further, BMS-309403 significantly inhibited tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 and monocyte chemotactic protein-1 as well as monocyte adhesion via preventing NF-κB activation. Interestingly, SMCs do not express FABP4. Long-term treatment of spontaneously hypertensive rats (SHR) with BMS-309403 significantly inhibited impaired relaxation in isolated mesenteric arteries and left ventricular hypertrophy, while it had no influence on SBP. We for the first time showed that FABP4 acutely enhances NA-induced increases of SBP possibly through the enhancement of peripheral arterial contractility. BMS-309403 prevents proliferation, migration, and inflammatory responses of SMCs, although exogenous application of FABP4 has no influence on the cellular responses. Furthermore, we demonstrated that long-term treatment with BMS-309403 partially improves the pathological conditions of SHR. These results indicate that BMS-309403 would be useful for developing a new pharmacotherapeutic agent against obesity-associated hypertension and complications.

Entities:  

Keywords:  Adipocytokine; Contractility; Hypertension; Inflammation; Migration; Proliferation; Vascular smooth muscle

Mesh:

Substances:

Year:  2017        PMID: 28405802     DOI: 10.1007/s00424-017-1976-0

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  40 in total

1.  FABP4 plasma levels are increased in familial combined hyperlipidemia.

Authors:  Anna Cabré; Iolanda Lázaro; Montserrat Cofán; Estibaliz Jarauta; Núria Plana; Angel L Garcia-Otín; Juan F Ascaso; Raimón Ferré; Fernando Civeira; Emilio Ros; Lluís Masana
Journal:  J Lipid Res       Date:  2010-05       Impact factor: 5.922

2.  Mechanisms underlying impairment of endothelium-dependent relaxation by fetal bovine serum in organ-cultured rat mesenteric artery.

Authors:  Tomoka Morita; Muneyoshi Okada; Yukio Hara; Hideyuki Yamawaki
Journal:  Eur J Pharmacol       Date:  2011-08-10       Impact factor: 4.432

3.  FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women.

Authors:  Ximena Terra; Yunuen Quintero; Teresa Auguet; Jose Antonio Porras; Mercé Hernández; Fátima Sabench; Carmen Aguilar; Anna María Luna; Daniel Del Castillo; Cristobal Richart
Journal:  Eur J Endocrinol       Date:  2011-01-21       Impact factor: 6.664

4.  Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

Authors:  K T Uysal; L Scheja; S M Wiesbrock; S Bonner-Weir; G S Hotamisligil
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

Review 5.  Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications.

Authors:  Hassan M E Azzazy; Maurice M A L Pelsers; Robert H Christenson
Journal:  Clin Chem       Date:  2005-11-03       Impact factor: 8.327

6.  Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.

Authors:  G S Hotamisligil; R S Johnson; R J Distel; R Ellis; V E Papaioannou; B M Spiegelman
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

7.  Olibanum extract inhibits vascular smooth muscle cell migration and proliferation in response to platelet-derived growth factor.

Authors:  Ok-Byung Choi; Joo-Hoon Park; Ye Jin Lee; Chang-Kwon Lee; Kyung-Jong Won; Junghwan Kim; Hwan Myung Lee; Bokyung Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-04-30       Impact factor: 2.016

8.  Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats.

Authors:  Tatsuya Usui; Muneyoshi Okada; Yukio Hara; Hideyuki Yamawaki
Journal:  Hypertension       Date:  2012-08-06       Impact factor: 10.190

9.  Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man.

Authors:  A H Kleine; J F Glatz; F A Van Nieuwenhoven; G J Van der Vusse
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

10.  Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells.

Authors:  Gemma Aragonès; Paula Saavedra; Mercedes Heras; Anna Cabré; Josefa Girona; Lluís Masana
Journal:  Cardiovasc Diabetol       Date:  2012-06-18       Impact factor: 9.951

View more
  3 in total

1.  Effects of host fatty acid-binding protein 4 on Eimeria tenella sporozoites invasion of cells.

Authors:  Lu Wang; Shunhai Zhu; Qiping Zhao; Bing Huang; Ling Lv; Guiling Liu; Zhihang Li; Huanzhi Zhao; Hongyu Han; Hui Dong
Journal:  Parasitol Res       Date:  2019-05-08       Impact factor: 2.289

2.  Diverse distribution of tyrosine receptor kinase B isoforms in rat multiple tissues.

Authors:  Kosuke Otani; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2017-07-29       Impact factor: 1.267

3.  Chemokine-like Receptor 1 in Brain of Spontaneously Hypertensive Rats Mediates Systemic Hypertension.

Authors:  Atsunori Yamamoto; Kosuke Otani; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  Int J Mol Sci       Date:  2021-10-30       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.